There is an increased susceptibility and mortality in the elderly due to pneumonia caused by Streptococcus pneumoniae. We aimed to assess the inflammatory cell composition with respect to age in pneumococcal pneumonia patients. Neutrophilic granulocytes and various lymphocyte and macrophage subpopulations were immunohistochemically quantified on lung tissue specimens of young (n = 5; mean age 8.4 years), middle-aged (n = 8; mean age 55.9 years) and elderly (n = 9; mean age 86.6 years) pneumonia patients with microbiologically proven S. pneumoniae pneumonia. We discovered a higher percentage of neutrophilic granulocytes in elderly as opposed to young patients (95 vs. 75%, p = 0.012). Conversely, young patients versus elderly patients had more alveolar macrophages (CD11c+: 20 vs. 9%, p = 0.029) and M1 macrophages (CD14+: 30 vs. 10%, p = 0.012 and HLA-DR+: 52 vs. 11%, p = 0.019). There was no significant difference concerning M2 macrophages and lymphocytes. Comparison of young patients with middle-aged patients showed similar significant results for alveolar macrophages (p = 0.019) and subsignificant results for M1 macrophages and neutrophilic granulocytes (p < 0.08). This is the first study characterizing the inflammatory infiltrate of pneumococcal pneumonia in situ. Our observations improve the understanding of the innate immune mechanisms of pneumococcal lung infection and point at the potential of therapies for restoring macrophage function and decreasing neutrophilic influx in order to help prevent or cure pneumonia.

Keywords:
Streptococcus pneumoniae pneumonia, Inflammatory infiltrate, Lymphocytes, Granulocytes, Macrophages
1.
Lynch JP 3rd, Zhanel GG: Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention. Semin Respir Crit Care Med 2009;30:189-209.
2.
Harboe ZB, Thomsen RW, Riis A, Valentiner-Branth P, Christensen JJ, Lambertsen L, Krogfelt KA, Konradsen HB, Benfield TL: Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 2009;6:e1000081.
3.
Janssens JP, Krause KH: Pneumonia in the very old. Lancet Infect Dis 2004;4:112-124.
4.
Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS, Farley MM, Jorgensen JH, Lexau CA, Petit S, Reingold A, Schaffner W, Thomas A, Whitney CG, Harrison LH: Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. New Engl J Med 2009;360:244-256.
5.
Jackson LA, Janoff EN: Pneumococcal vaccination of elderly adults: new paradigms for protection. Clin Infect Dis 2008;47:1328-1338.
6.
Huss A, Scott P, Stuck AE, Trotter C, Egger M: Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 2009;180:48-58.
7.
Ortqvist A, Hedlund J, Burman LA, Elbel E, Hofer M, Leinonen M, Lindblad I, Sundelof B, Kalin M: Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group. Lancet 1998;351:399-403.
8.
Simberkoff MS, Cross AP, Al-Ibrahim M, Baltch AL, Geiseler PJ, Nadler J, Richmond AS, Smith RP, Schiffman G, Shepard DS, et al: Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. New Engl J Med 1986;315:1318-1327.
9.
Kadioglu A, Andrew PW: The innate immune response to pneumococcal lung infection: the untold story. Trends Immunol 2004;25:143-149.
10.
Lipsitch M, Whitney CG, Zell E, Kaijalainen T, Dagan R, Malley R: Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease? PLoS Med 2005;2:e15.
11.
Musher DM, Groover JE, Rowland JM, Watson DA, Struewing JB, Baughn RE, Mufson MA: Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination. Clin Infect Dis 1993;17:66-73.
12.
Malley R, Trzcinski K, Srivastava A, Thompson CM, Anderson PW, Lipsitch M: CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci USA 2005;102:4848-4853.
13.
Trzcinski K, Thompson C, Malley R, Lipsitch M: Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model. Infect Immun 2005;73:7043-7046.
14.
Lu YJ, Gross J, Bogaert D, Finn A, Bagrade L, Zhang Q, Kolls JK, Srivastava A, Lundgren A, Forte S, Thompson CM, Harney KF, Anderson PW, Lipsitch M, Malley R: Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 2008;4:e1000159.
15.
Zhang Z, Clarke TB, Weiser JN: Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 2009;119:1899-1909.
16.
Schmid P, Selak S, Keller M, Luhan B, Magyarics Z, Seidel S, Schlick P, Reinisch C, Lingnau K, Nagy E, Grubeck-Loebenstein B: Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age. Vaccine 2011;29:3982-3989.
17.
Olliver M, Hiew J, Mellroth P, Henriques-Normark B, Bergman P: Human monocytes promote Th1 and Th17 responses to Streptococcus pneumoniae. Infect Immun 2011;79:4210-4217.
18.
Murray PJ, Wynn TA: Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011;11:723-737.
19.
Aberdein J, Cole J, Bewley M, Dockrell DH: Alveolar macrophages in pulmonary host defence - the unrecognised role of apoptosis as a mechanism of intracellular bacterial killing. Clin Exp Immunol 2013;174:193-202.
20.
Biswas SK, Mantovani A: Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010;11:889-896.
21.
Duan M, Li WC, Vlahos R, Maxwell MJ, Anderson GP, Hibbs ML: Distinct macrophage subpopulations characterize acute infection and chronic inflammatory lung disease. J Immunol 2012;189:946-955.
22.
van Rijt LS, Jung S, Kleinjan A, Vos N, Willart M, Duez C, Hoogsteden HC, Lambrecht BN: In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma. J Exp Med 2005;201:981-991.
23.
Ziegler-Heitbrock HW, Ulevitch RJ: CD14: cell surface receptor and differentiation marker. Immunol Today 1993;14:121-125.
24.
Buhling F, Ittenson A, Kaiser D, Tholert G, Hoffmann B, Reinhold D, Ansorge S, Welte T: MRP8/MRP14, CD11b and HLA-DR expression of alveolar macrophages in pneumonia. Immunol Lett 2000;71:185-190.
25.
Hogger P, Dreier J, Droste A, Buck F, Sorg C: Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J Immunol 1998;161:1883-1890.
26.
Meyer KC, Rosenthal NS, Soergel P, Peterson K: Neutrophils and low-grade inflammation in the seemingly normal aging human lung. Mech Ageing Dev 1998;104:169-181.
27.
Lord JM, Butcher S, Killampali V, Lascelles D, Salmon M: Neutrophil ageing and immunesenescence. Mech Ageing Dev 2001;122:1521-1535.
28.
Shaw AC, Joshi S, Greenwood H, Panda A, Lord JM: Aging of the innate immune system. Curr Opin Immunol 2010;22:507-513.
29.
Gomez CR, Nomellini V, Faunce DE, Kovacs EJ: Innate immunity and aging. Exp Gerontol 2008;43:718-728.
30.
Weinberger B, Herndler-Brandstetter D, Schwanninger A, Weiskopf D, Grubeck-Loebenstein B: Biology of immune responses to vaccines in elderly persons. Clin Infect Dis 2008;46:1078-1084.
31.
Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G: Inflamm-aging. An evolutionary perspective on immunosenescence. Ann NY Acad Sci 2000;908:244-254.
32.
Benoit M, Desnues B, Mege JL: Macrophage polarization in bacterial infections. J Immunol 2008;181:3733-3739.
33.
Shibata Y, Berclaz PY, Chroneos ZC, Yoshida M, Whitsett JA, Trapnell BC: GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity 2001;15:557-567.
34.
Dockrell DH, Marriott HM, Prince LR, Ridger VC, Ince PG, Hellewell PG, Whyte MK: Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection. J Immunol 2003;171:5380-5388.
35.
Jensen-Fangel S, Mohey R, Johnsen SP, Andersen PL, Sorensen HT, Ostergaard L: Gender differences in hospitalization rates for respiratory tract infections in Danish youth. Scand J Infect Dis 2004;36:31-36.
36.
Falagas ME, Mourtzoukou EG, Vardakas KZ: Sex differences in the incidence and severity of respiratory tract infections. Respir Med 2007;101:1845-1863.
37.
Meydani SN, Barnett JB, Dallal GE, Fine BC, Jacques PF, Leka LS, Hamer DH: Serum zinc and pneumonia in nursing home elderly. Am J Clin Nutr 2007;86:1167-1173.
38.
Stout RD, Suttles J: Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes. Immunol Rev 2005;205:60-71.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.